DRESS syndrome related to Hexaquine® (quinine and thiamine);Syndrome d'hypersensibilité médicamenteuse à l'Hexaquine® (quinine et thiamine)

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 4, 2006, Pages 354-358

  Greco M ^a   Dupre Goetghebeur D ^a   Leroy, J P ^a   Karam, A ^a   Jantzem, H ^a   Sassolas, B ^a   Misery, L ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DNA; HEXAQUINE; IMMUNOGLOBULIN G; QUININE DERIVATIVE; QUININE PLUS THIAMINE; THIAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHENIA; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; CYTOLYTIC HEPATITIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME; ENTEROVIRUS; ERYTHRODERMA; FACE EDEMA; FEMALE; FEVER; HEPATITIS; HUMAN; HUMAN HERPESVIRUS 6; HYPOGAMMAGLOBULINEMIA; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LABORATORY TEST; LYMPHOCYTE; MUSCLE CRAMP; NONHUMAN; POLYMERASE CHAIN REACTION; RASH; SCREENING; SEROLOGY;

EID: 33744916518     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(06)70914-0     Document Type: Article

References (26)

1. Begon E, Roujeau JC. Syndrome d'hypersensibilité médicamenteuse ou DRESS. Ann Dermatol Venereol 2004;131:293-7.
2. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-72.
3. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, etal. Human herpes virus 6 infection associated with anticonvulsivant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-8.
4. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.
5. Descamps V, Collot S, Mahe E, Houhou N, Crickx B, Ranger-Rogez S. Active human herpesvirus 6 infection in a patient with drug reaction with eosinophilia and systemic symptoms. J Invest Dermatol 2003;121:215-6.
6. Tohyama M, Hashimoto K. Drug hypersensitivity syndrome and HHV6 reactivation. Arch Dermatol 2002;138:268-9.
7. Tas S, Simonart T. Management of drug reaction with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206:353-6.
8. Merpit-Gonon E, Misery L, Michel JL, et al. Syndrome d'hypersensibilité à la carbamazépine. Nouv Dermatol 2001;20:7-11.
9. Bonnetblanc JM. Drug hypersensitivity syndrome. Dermatology 1993;187:84-5.
10. Kanny G, Renaudin JM, Moneret-Vautrin DA. Chloroquine hypersensitivity syndrome. Eur J Int Med 2002;13:75-6.
11. n. Gonzales R, Merchan R, Rodriguez J. Allergic urticaria from tonic water. Allergy 2002;57:52-64.
12. Asero R. Fixed drug eruptions caused by tonic water. J Allergy Clin Immunol 2003;111:198-9.
13. Nyunga M, Meybeck A, Wallaert B, Just N. Allergie aux APS : à propos de deux cas. Rev Fr Allergol Clin Immunol 2004;44:155-8.
14. Cany I. Allergie à la qui nine. Rev Fr Allergol Clin Immunol 1966;6:112-3.
15. Price EJ, Bevan JS, Rees A. Quinine-induced cutaneous vasculitis. Br J Clin Pract 1992;46:138-9.
16. Okun MM, Henner M, Paulson C. A quinine-induced drug reaction of photosensitive distribution with histological features mimicking mycosis fungoides. Clin Exp Dermatol 1994;19:246-8.
17. Marthur S, Dooley J, Scheueuer PJ. Quinine induced granulomatous hepatitis. Br Med J 1990;300:613.
18. Beyens MN, Guy C, Ollagnier M. Effets indésirables de la quinine dans l'indication des crampes musculaires. Thérapie 1999;54:59-62.
19. Masaki T, Fukunaga A, Tohyama M, Koda Y, Okuda S, Maeda N, et al. HHV6 Encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 2003;83:128-31.
20. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B. Drug induced hypersensitivity syndrome associated with EBV infection. Br J Dermatol 2003;148:1032-4.
21. Aihara M, Sugita Y, Takahashi S, Nagatani T, Arata S, Takeuchi K, et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of CMV. Br J Dermatol 2001;144:1231-4.
22. Regnier S, Descamps V, Boui M, Lebrun-Vignes B, Descamps D, Grossin M, et al. Primo-infection à parvovirus B19 mimant un syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Venereol 2000;127:505-6.
23. Kosseian-Bal I, Bocquet H, Beneton N, Encaoua R, Deforges L, Roujeau JC, et al. Syndrome d'hypersensibilité durant une infection à mycoplasma pneumoniae. Ann Dermatol Venereol 1998;125:328-30.
24. Cordel N, Lenormand B, Courville P, Joly P. Étude de la clonalité des lymphocytes cutanés et sanguins au cours du syndrome d'hypersensibilité médicamenteuse chez 6 malades. Ann Dermatol Venereol 2004;131:1059-61.
25. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and Human Herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004;140:183-8.
26. Morand JJ, Lightburn E, Coton T, Carre D, Chouc C, Debonne JM, et al. Syndrome d'hypersensibilité médicamenteuse rapidement résolutif après perfusion d'immunoglobulines humaines. Ann Dermatol Venereol 2001;128:1351-3.